Cancer/Tumor Profiling Market By Technology, Technique, - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018–2026 Cancer profiling is a technique used to classify tumors more accurately, which helps in predicting the patient’s clinical outcome. Cancer/Tumor profiling helps in identification of genomic alteration, which aid to select an appropriate therapy for the treatment of cancer. This technique reduces the trial and error process in diagnosis of cancer at various stages and provide more precise and accurate information about clinical outcomes of cancer. Different tests are used in the diagnosis of cancer such as laboratory test (blood and urine), biopsy, imaging test (X-ray, MRI, PET/CT, and ultrasound), nuclear medicine scan, and lumber puncture, which is unable to identify exact cause of cancer in early stages. This can be led to over-treatment of cancer patients. Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/967 According to the World Health Organization (WHO), nearly 1 in 6 deaths occurs due to cancer and around 8.8 million people died from cancer worldwide in 2015. Increasing incidence and prevalence of different cancers among individuals augmented the demand for accurate diagnosis of cause in early stage of cancer. Emergence of cancer profiling over traditional cancer diagnostic methods is expected to gain growth of the Cancer/Tumor profiling market: St. Jude Medical Center's Crosson Cancer Institute has joined Caris’ Precision Oncology Alliance (POA) as its 17th member in 2017. POA is established by Caris Life Sciences to promote the appropriate use of molecular tool in diagnosis and treatment of cancer. The St. Jude Medical Center's Crosson Cancer Institute will help Caris Life Sciences to develop standard and best practices to make cancer treatment more effective and precise by advancing the use of tumor profiling. EpiVax Inc. launched EpiVax Oncology Inc., which is an approach for precision cancer immunotherapy in 2017. EpiVax used molecular profiling through Next-Generation Sequencing (NGS) to produce therapeutic vaccines for cancer. Personal Genome Diagnostics Inc. launched CancerSELECT 125 test for pan-cancer tumor profiling in 2016. CancerSELECT 125 identify tumor specific functional sequence mutation in multiple cancer types with high accuracy. Report includes chapters which deeply display the following deliverable about industry : • Cancer/Tumor Profiling Market Research Objective and Assumption • Cancer/Tumor Profiling Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Cancer/Tumor Profiling Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Cancer/Tumor Profiling Market, By Regions • Cancer/Tumor Profiling Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Cancer/Tumor Profiling Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Cancer/Tumor Profiling Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Cancer/Tumor Profiling Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Some of the major key players operating in the global cancer profiling market include Proteome Sciences PLC, Life Technologies Corporation, Illumina, Inc., BioTheranostics, RiboMed Biotechnologies Inc., NeoGenomics Laboratories, Oxford Gene Technology Ltd., Genomic Health Inc., Agendia, and Oncopath Laboratories. Cancer Profiling Market Taxonomy By Technology • Microarray • Next-Generation Sequencing (NGS) • Quantitative Polymerase Chain Reaction (QPCR) • Immunohistochemistry (IHC) • In Situ Hybridization (ISH) • Fluorescence In Situ Hybridization (FISH) • Chromogenic In Situ Hybridization (CISH) By Technique • Genomics • Proteomics • Epigenetics • Metabolomics By Application • Diagnostics • Personalized Medicine • Biomarker Discovery • Prognostics • Others (Research Applications) About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: sales@coherentmarketinsights.com
Cancer profiling is a technique used to classify tumors more accurately, which helps in predicting the patient’s clinical outcome.
© Copyright 2024 Paperzz
